BBIO

BBIO EBITDA Margin

-85.72%TTM

Period ending:

BBIO FY EBITDA Margin%
BBIO FY EBITDA Margin729.40%-6807.74%
2017-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

BBIO ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 9 observations from Dec 31, 2017 to Dec 31, 2025.

Bridgebio Pharma Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
-134.7299%
-196.8567%
-6,078.3403%
-511.8522%
-765.7252%
-5,665.8625%
-687.7737%
0%
0%

Compare ebitda margin

All BBIO financial metrics · BBIO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.